Syra Health Corp (SYRA): Submission of Matters to a Vote of Security Holders
Syra Health Corp (SYRA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001922335 0001922335 2026-07-23 2026-07-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor
How this was made
The 30-second read
Why it matters
Director nominees were elected, the independent auditor was ratified, and the 2022 Omnibus Equity Incentive Plan was amended to increase Class A shares available for issuance to 4,100,000.
Market read
This is a procedural disclosure of shareholder vote outcomes, with limited direct trading implications absent new financial or strategic information.
What to watch
Because the company is OTCQB-listed, liquidity and microstructure effects may dominate any short-term reaction; the 8-K itself does not quantify dilution or near-term capital needs.
Background
The company’s 8-K (Item 5.07) summarizes matters submitted to stockholders at its Annual Meeting on July 23, 2026.
Ticker impact
Syra Health filed an 8-K reporting Annual Meeting results, including director elections and ratification of its independent auditor for FY ended Dec. 31, 2026.
Low likelihood of a sustained price move based solely on these vote tallies.
Item 5.07 discloses voting outcomes (directors elected, auditor ratified, equity plan amended) without introducing new operating or financial metrics.
Market effects
Minimal. Governance and equity-plan approval typically do not change sector fundamentals immediately.
None indicated.
None indicated.
Counterpoint
The equity incentive plan share increase could modestly affect future dilution expectations, but the filing provides no pricing or issuance details.
Key entities
- issuerSyra Health Corp
OTCQB-listed company filing Item 5.07 results from its Annual Meeting of stockholders.
- auditorM&K CPAs, PLLC
Independent registered public accounting firm ratified for the fiscal year ended December 31, 2026.
- equity_compensation2022 Omnibus Equity Incentive Plan
Amended to increase Class A shares available for issuance to 4,100,000.
